RxDoctor Payments Data

Karen Root, NP

Family · Lyons, KSNPI 1053585836

Payments from drug & device makers

$776in general payments, 2019–2025

Across 46 payments — averaging $16.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$223
  • Novartis$148
  • Amgen$100
  • Novo Nordisk$97
  • Lilly USA, LLC$69
  • Pfizer$48
  • plus $93 from 5 others

What the payments were for

  • Food & beverage$776100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$776 in reported general payments places this provider in the 65th percentile of 1,579 family providers in Kansas.

See all family providers in Kansas

Medicare billing

Part B allowed, 2024
$2,831
Medicare patients
22
Services billed
37

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole-Sodium BicarbonateOmeprazole/Sodium Bicarbonate21$38,824
JardianceEmpagliflozin41$26,020
OzempicSemaglutide20$23,830
TrulicityDulaglutide18$17,533
MounjaroTirzepatide17$15,720
JanuviaSitagliptin Phosphate23$13,624
TradjentaLinagliptin14$6,852
Spiriva RespimatTiotropium Bromide13$6,846
EliquisApixaban12$6,782
Combivent RespimatIpratropium/Albuterol Sulfate11$6,071
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$5,776
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen94$3,922
BreynaBudesonide/Formoterol Fumarate11$3,067
Arnuity ElliptaFluticasone Furoate11$2,506
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$2,409

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$69$33,25235 claims
Novo NordiskOzempic$97$23,83020 claims
PfizerEliquis$48$6,78212 claims
AbbVieSynthroid$223$44813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,579 family providers in Kansas.

Other family in Lyons

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →